CBS-FTD Overlap Syndrome

CBS-FTD Overlap Syndrome

Overview

The relationship between Corticobasal Syndrome (CBS) and Frontotemporal Dementia (FTD) represents one of the most clinically and pathologically complex intersections in the spectrum of neurodegenerative disorders. While CBS and FTD were historically described as distinct clinical entities, accumulating evidence demonstrates substantial clinical, pathological, and genetic overlap, leading to recognition of a continuum of disorders rather than strictly separable diseases[@boe2019].

CBS can result from various underlying pathologies including corticobasal degeneration (CBD, a 4R tauopathy), Alzheimer's disease (AD), frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), and less commonly, alpha-synucleinopathy. This pathological heterogeneity explains the significant clinical overlap with FTD spectrum disorders, particularly behavioral variant FTD (bvFTD) and the language variants[@dickson2024].

Clinical Overlap

Shared Clinical Features

CBS and FTD demonstrate significant overlap in their clinical presentations:

CBS-FTD Overlap Syndrome

Overview

The relationship between Corticobasal Syndrome (CBS) and Frontotemporal Dementia (FTD) represents one of the most clinically and pathologically complex intersections in the spectrum of neurodegenerative disorders. While CBS and FTD were historically described as distinct clinical entities, accumulating evidence demonstrates substantial clinical, pathological, and genetic overlap, leading to recognition of a continuum of disorders rather than strictly separable diseases[@boe2019].

CBS can result from various underlying pathologies including corticobasal degeneration (CBD, a 4R tauopathy), Alzheimer's disease (AD), frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP), and less commonly, alpha-synucleinopathy. This pathological heterogeneity explains the significant clinical overlap with FTD spectrum disorders, particularly behavioral variant FTD (bvFTD) and the language variants[@dickson2024].

Clinical Overlap

Shared Clinical Features

CBS and FTD demonstrate significant overlap in their clinical presentations:

| Feature | CBS | FTD (bvFTD) | Overlap Significance |
|---------|-----|-------------|----------------------|
| Cognitive dysfunction | Frontal executive, cortical | Frontal executive, behavioral | Both show prominent cognitive decline |
| Language impairment | Nonfluent aphasia common | Primary phenotype in svPPA/nfvPPA | Shared language network involvement |
| Behavioral changes | Apathy, disinhibition | Core bvFTD features | Prefrontal cortex involvement |
| Apraxia | Prominent (ideomotor) | Variable | Cortical sensorimotor involvement |
| Personality changes | Progressive | Core feature | Frontal lobe degeneration |
| Executive dysfunction | Severe | Prominent | Shared frontal circuit dysfunction |

CBS Presenting as FTD Phenotype

Patients with CBS can present with clinical features indistinguishable from bvFTD[@suenaga2024]:

Clinical Characteristics:

• Early behavioral disinhibition (loss of social conduct, inappropriate jokes)
• Apathy and loss of motivation
• Compulsive/ritualistic behaviors
• Early loss of empathy and social cognition deficits
• Prominent executive dysfunction

• Asymmetric motor onset (even in FTD-phenotype CBS)
• Presence of cortical signs (apraxia, cortical sensory loss)
• Myoclonus (cortical origin)
• Alien limb phenomenon

FTD Presenting as CBS

Conversely, some patients with pathologically confirmed FTD (particularly FTLD-TDP) present with CBS phenotype:

Clinical Characteristics:

• Asymmetric onset of parkinsonism
• Prominent apraxia
• Cortical sensory loss
• Alien limb phenomena
• Early myoclonus

• Usually less prominent oculomotor dysfunction than CBS
• More rapid progression in some cases
• Family history more common in GRN-associated cases

Language Variant Overlap

Both CBS and FTD demonstrate significant language impairment[@flabeau2024]:

Nonfluent/Agrammatic Variant Features:

• Agrammatic speech (telegraphic, missing function words)
• Motor speech impairment (apraxia of speech)
• Simplified sentence structure
• Preserved comprehension early

• Loss of word meaning (anomia, empty speech)
• Object knowledge deficits
• Surface dyslexia
• Usually more prominent in FTD but can occur in CBS

Cognitive and Neuropsychiatric Overlap

The cognitive profiles in CBS and FTD show substantial similarity[@niccolini2022]:

Shared Cognitive Features:

• Executive dysfunction (set-shifting, planning, inhibition)
• Working memory impairment
• Visuospatial deficits (prominent in CBS)
• Language dysfunction (naming, fluency)

• Apathy (most common, ~70%)
• Depression (40-50%)
• Anxiety (30-40%)
• Irritability/aggression
• Loss of empathy
• Impaired social cognition

Pathological Overlap

Tau Pathology (CBD-FTD)

The majority of CBS cases with CBD pathology show significant overlap with FTD[@dickson2024]:

Key Pathological Features:

• Neuronal loss and gliosis in frontal and parietal cortices
• 4-repeat tau isoforms in astrocytic plaques and threads
• Subcortical involvement (basal ganglia, brainstem)
• Variable involvement of motor cortex and corticospinal tract

TDP-43 Pathology (FTLD-TDP)

Approximately 40-50% of CBS cases show TDP-43 pathology, creating direct overlap with FTLD-TDP[@rugiero2023]:

TDP-43 Subtypes in CBS:

• Type A (MND-type): Common in GRN mutations
• Type B (FTLD-B): More common in C9orf72
• Type C ( sclerotic): Less common in CBS

• TDP-43 pathology in CBS associated with:
• More prominent language impairment
• Earlier cognitive decline
• More rapid progression
• Family history in ~30% of cases

Mixed Pathology

Some CBS cases show multiple underlying pathologies[@kouri2021]:

• CBD + AD pathology (most common mixed)
• CBD + TDP-43 pathology
• AD + TDP-43 pathology (fewer)
• Tau + alpha-synuclein (rare)

Genetic Overlap

Shared Genetic Risk Factors

CBS and FTD share common genetic architecture[@chen2021]:

Major Shared Genes:

| Gene | CBS | FTD | Mechanism |
|------|-----|-----|-----------|
| MAPT | +++ | +++ | Tau mutations cause 4R tauopathy |
| GRN | ++ | +++ | Progranulin haploinsufficiency -> TDP-43 pathology |
| C9orf72 | ++ | +++ | Hexanucleotide repeats -> DPR toxicity |
| TMEM106B | + | ++ | Risk factor for FTLD-TDP |
| VCP | + | ++ | Aggregate clearance dysfunction |

GRN Mutations in CBS

Progranulin (GRN) mutations are a significant cause of CBS-FTD overlap[@morris2023]:

Clinical Features:

• Earlier age of onset (typically 50-70)
• Prominent language dysfunction (aphasia)
• Cortical atrophy on MRI
• TDP-43 pathology at autopsy

• Prominent word-finding difficulty
• Impaired naming
• Executive dysfunction
• Memory relatively preserved early

Genetic Testing Implications

The overlap has important implications for genetic testing:

• GRN testing recommended in CBS with family history
• C9orf72 testing important in CBS-FTD overlap
• MAPT testing for tauopathy presentations
• TMEM106B as risk modifier

Network-Level Overlap

Functional Connectivity Changes

Resting-state fMRI studies reveal shared network dysfunction in CBS and FTD[@rangaprakash2023]:

Network Findings:

• Salience Network disruption (shared)
• Default Mode Network fragmentation
• Executive network dysfunction
• Language network involvement

Structural Connectivity

DTI studies show overlapping white matter involvement:

• Corpus callosum (anterior > posterior)
• Superior longitudinal fasciculus
• Uncinate fasciculus
• Anterior thalamic radiations

Diagnostic Implications

Clinical Recognition of CBS-FTD Overlap

Recognizing CBS-FTD overlap is critical for:

• FTD-phenotype CBS may have faster progression
• TDP-43 pathology associated with earlier cognitive decline
• Family history important for genetic counseling

• CBS patients may benefit from FTD-targeted trials
• Inclusion of CBS in FTD trials expands enrollment
• Biomarker stratification important

• No disease-modifying treatments for either
• Symptomatic treatments similar
• Behavioral interventions applicable to both

Biomarker Overlap

Shared biomarkers include:

• FDG-PET: Frontal hypometabolism in both
• Tau PET: Variable uptake in CBS (often negative)
• CSF: Elevated neurofilament light (NfL) in both
• MRI: Frontal/temporal atrophy pattern similarity

Management Considerations

Shared Management Strategies

| Domain | CBS | FTD | Shared Approach |
|--------|-----|-----|-----------------|
| Motor symptoms | Physical therapy, OT | Limited | Functional maintenance |
| Cognitive | Compensatory strategies | Compensatory strategies | Similar techniques |
| Behavioral | Environmental modification | Environmental modification | Primary approach |
| Pharmacological | Limited efficacy | Limited efficacy | Symptomatic only |
| Support | Caregiver support | Caregiver support | Critical for both |

Specific Considerations for Overlap

When CBS and FTD features coexist:

Research Directions

Key Unanswered Questions

• Why do some patients present as CBS vs FTD?
• Role of regional pathology distribution
• Contribution of genetic modifiers

• Antemortem differentiation of pathologies
• Blood-based biomarkers for stratification
• Tau vs TDP-43 vs AD prediction

• Does FTD treatment work in CBS?
• Targeted therapies for specific pathologies
• Trial design for overlap syndromes

• Progression patterns in overlap vs pure forms
• Predictors of phenotype switching
• Survival differences

See Also

Related Pages

• [Corticobasal Syndrome](/diseases/cortico-basal-syndrome)
• [Frontotemporal Dementia](/diseases/ftd)
• [PSP-CBD Overlap Syndrome](/diseases/psp-cbd-overlap)
• [4R Tauopathies](/mechanisms/4r-tauopathies)
• [TDP-43 Pathology in CBS](/mechanisms/tdp-43-cbs)
• [GRN Gene](/genes/grn)
• [C9orf72 Repeat Expansions](/genes/c9orf72)

Related Mechanisms

• [Frontotemporal Lobar Degeneration](/mechanisms/ftd-tdp-pathway)
• [Tau Network Propagation](/mechanisms/tau-network-propagation-hypothesis)
• [Cognitive Dysfunction in 4R Tauopathies](/mechanisms/synaptic-dysfunction-4r-tauopathies)

References